Skip to content

Adding cycling to usual depression care showed no clear overall advantage

A small trial examined whether immune-cell patterns predicted remission with added cycling. Its overall result and exploratory subgroup signal need to be considered together.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

Adding cycling to usual care did not show superior outcomes across the full depression sample. Researchers found a possible remission signal in a small subgroup selected after examining immune-cell patterns. That finding is exploratory: it does not establish that immune testing can identify who should receive cycling therapy or that this subgroup alone can benefit.

Keep in mind

Researchers defined the subgroup after examining the data, and it was very small. The authors call for larger confirmatory studies; the abstract does not quantify the overall treatment difference.

THE NUMBERS, WITH CONTEXT

What researchers found

75% versus 17%

Depression remission in an exploratory immune-defined subgroup

At week 24, cycling plus usual care (n = 8) versus usual care alone (n = 12); p = 0.03. Subgroup selected after examining baseline immune-cell profiles.

Brain Behav Immun, 2026 · Original source ↓

The main research question

The main question was whether immune-cell patterns measured before cycling distinguished participants who later reached depression remission. Researchers studied a potential predictor while also comparing outcomes for added cycling and usual care alone.

Immune changes and recovery

Added cycling did not significantly change CD8+ memory T cells, a type of immune cell. Other immune-cell shifts occurred in the subgroup, but laboratory changes alone do not establish depression remission.

CHECK THE ORIGINAL

The original publication

One treatment does not fit all: Indications that spinning therapy benefits only a subgroup of patients with depression characterized by a T memory cell inflation profile.

Fromme SE, Arteaga-Henríquez G, Haarman BCM et al.
Brain Behav Immun · 2026

PubMed ID
41421730
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.